1. Additional file 1 of A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer
- Author
-
Schinke, Henrik, Shi, Enxian, Lin, Zhongyang, Quadt, Tanja, Kranz, Gisela, Zhou, Jiefu, Wang, Hongxia, Hess, Julia, Heuer, Steffen, Belka, Claus, Zitzelsberger, Horst, Schumacher, Udo, Genduso, Sandra, Riecken, Kristoffer, Gao, Yujing, Wu, Zhengquan, Reichel, Christoph A., Walz, Christoph, Canis, Martin, Unger, Kristian, Baumeister, Philipp, Pan, Min, and Gires, Olivier
- Abstract
Additional file 1: SupplementaryFigure 1. Copy number variation and expression of EGFR in Kyse30and FaDu cells. Supplementary Figure 2. GSEA of EGF- and EpEX-treated Kyse30and FaDu cells. Supplementary Figure 3. Over-representation analysis of genesof the EGFR-mediated EMT signature. SupplementaryFigure 4. Comparison ofEGFR-mediated EMT, pEMT, and EMT signatures. Supplementary Figure 5. Comparisonof EMT signatures for prognostic purposes.Supplementary Figure 6. ITGB4,ITGA6, LAMA3, LAMB3, and LAMC2 expression in HNSCC. Supplementary Figure 7. ITGB4expression in malignant and non-malignant single cells in different cancerentities. Supplementary Figure 8. ITGA6 expression in malignant andnon-malignant single cells in different cancer entities. Supplementary Figure 9. LAMA3expression in malignant and non-malignant single cells in different cancerentities. Supplementary Figure 10. LAMB3 expression in malignant andnon-malignant single cells in different cancer entities. Supplementary Figure 11. LAMC2expression in malignant and non-malignant single cells in different cancerentities. Supplementary Figure 12. ITGB4 expression in knockdown clonesof Kyse30 and FaDu cells. Supplementary Figure 13. Wound healing capacity of control andITGB4-knockdown cell lines. SupplementaryFigure 14. Tumor buddingintensities in HNSCC.
- Published
- 2022
- Full Text
- View/download PDF